USP10 and neoplasm: For example, as AMPK-mediated phosphorylation of USP10 enhances USP10 activity69, treatment with metformin, which is used clinically to activate AMPK112, can lead to the upregulation of USP10 and, thus, PTEN-induced tumor suppression.